Skip to main content
Molecular Therapy logoLink to Molecular Therapy
. 2025 Jul 30;33(9):4655. doi: 10.1016/j.ymthe.2025.07.035

Retraction Notice to: Intra-articular Delivery of Antago-miR-483-5p Inhibits Osteoarthritis by Modulating Matrilin 3 and Tissue Inhibitor of Metalloproteinase 2

Hua Wang, Haiyan Zhang, Qiuyi Sun, Yun Wang, Jun Yang, Jincheng Yang, Tao Zhang, Shenqiu Luo, Liping Wang, Yu Jiang, Chun Zeng , Daozhang Cai ∗∗, Xiaochun Bai ∗∗∗
PMCID: PMC12432896  PMID: 40744012

Main text

(Molecular Therapy 25, 715–727; March 2017)

Molecular Therapy is retracting this article at the request of the editor-in-chief. Corresponding author Xiaochun Bai contacted the editorial office to request a correction of Figures 3B, 4C, and 7B. Image analysis performed by the editorial office revealed evidence of image duplication in identical or altered fashion involving Figures 2E, 3A, 3B, 4C, 7B, and 7E of this article. This reuse of data without appropriate attribution represents a severe abuse of the scientific publishing system. The authors did not agree to retract this article.

Contributor Information

Chun Zeng, Email: zengdavid@126.com.

Daozhang Cai, Email: daozhang@medmail.com.cn.

Xiaochun Bai, Email: baixc15@smu.edu.cn.


Articles from Molecular Therapy are provided here courtesy of The American Society of Gene & Cell Therapy

RESOURCES